** Shares of Proteomics International Laboratories surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8
** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis
** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO
** The condition takes an average of seven years to diagnose
** PIQ sets sights on Q2 CY25 for Australian launch of its product
** Stock hits its highest level since Oct. 29
** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.